A Phase IIB, Randomized, Double-blind, Two-arm, Multi-center, Placebo-controlled, Study to Assess the Efficacy and Safety of EN3324 (Axomadol) in Subjects With Moderate to Severe Chronic Low Back Pain
Phase of Trial: Phase II
Latest Information Update: 08 Apr 2015
At a glance
- Drugs Axomadol (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 30 Jun 2011 Primary endpoint 'Clinical-response' has not been met.
- 07 Jun 2011 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.